30
Oversold
Moving averages
SMA 200$1.10-62.48%
Company profile
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$167.22M
P/E ratioNone
EPS$-0.33
Beta1.295
Dividend yield0.00%
52-week high$3.07
52-week low$0.53
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
ARTV
Artiva Biotherapeutics Inc
RSI 23
TRDA
Entrada Therapeutics Inc
RSI 49
NERV
Minerva Neurosciences Inc
RSI 36
SAVA
Cassava Sciences Inc
IMUX
Immunic Inc
RSI 45
ARCT
Arcturus Therapeutics Holdings Inc
RSI 36
RSI alerts for IVVD
An email when IVVD closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 6:26 AM EST